Arginine-rich coconut kernel diet influences nitric oxide synthase activity in alloxandiabetic rats

Journal of the Science of Food and Agriculture

Volumn 92, Issue 9, 2012, Pages 1903-1908

  Salil, Gopalakrishnan ^a,c   Nevin, Kottayath G ^a,b   Rajamohan, Thankappan ^a  

^a UNIVERSITY OF KERALA   (India)

^b Sree Narayana Guru Institute of Science and Technology   (India)

^c Mar Baselios Dental College ^*  (India)

Author keywords

Arginine; Coconut protein; Diabetes; Nitric oxide synthase

Indexed keywords

ANTIOXIDANT; ARGINASE; ARGININE; GLYCOGEN; INSULIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PLANT MEDICINAL PRODUCT; VEGETABLE PROTEIN;

ANIMAL; ARTICLE; BLOOD; CHEMISTRY; COCONUT; DIET; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; LIVER; MALE; METABOLISM; PANCREAS; PATHOLOGY; PHYTOTHERAPY; PLANT SEED; PROTEIN INTAKE; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIOXIDANTS; ARGINASE; ARGININE; BLOOD GLUCOSE; COCOS; DIABETES MELLITUS, EXPERIMENTAL; DIET; DIETARY PROTEINS; GLYCOGEN; INSULIN; LIVER; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PANCREAS; PHYTOTHERAPY; PLANT PREPARATIONS; PLANT PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; SEEDS; SIGNAL TRANSDUCTION;

ANIMALIA; RATTUS;

EID: 84861983758     PISSN: 00225142     EISSN: 10970010     Source Type: Journal    
DOI: 10.1002/jsfa.5558     Document Type: Article

References (42)

1. Haller H, Drab M Luft FC, The role of hyperglycemia and hyperinsulinemia in the pathogenesis of diabetic angiopathy. Clin Nephrol 46: 246-255 (1996).
2. Nathan DM, Meigs J Singer DE, The epidemiology of cardiovascular disease in type 2 diabetes mellitus: how sweet it is... or is it? Lancet 350: SI4-SI9 (1997).
3. Williams SB, Cusco JA Roddy MA, Impaired nitric oxide-mediated vasodilation in patients with non-insulin dependent diabetes mellitus. J Am Coll Cardiol 27: 567-574 (1996).
4. Veves A, Akbari CM Primavera J, Endothelial dysfunction and the expression of endothelial nitric oxide synthase in diabetic neuropathy, vascular disease and foot ulceration. Diabetes 47: 457-463 (1998).
5. Mendez JD De Haro-Hernandez R, L-Arginine and polyamine administration protect cells against alloxan diabetogenic effect in Sprague-Dawley rats. Biomed Pharmacother 59: 283-289 (2005).
6. Maritim AC, Sanders RA Watkins JB, Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 17: 24-28 (2003).
7. Linn T, Geyer R, Prassek S Laube H, Effect of dietary protein intake on insulin secretion and glucose metabolism in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 81: 3938 (1996).
8. Prada FJ, Luciano E, Carneiro EM, Boschero AC Mello MA, Protein deficiency attenuates the effects of alloxan on insulin secretion and glucose homeostasis in rats. Physiol Chem Phys Med NMR 33: 73-82 (2001).
9. Gannon MC, Nuttall JA Nuttall FQ, Oral arginine does not stimulate and increase in insulin concentration but delays glucose disposal. Am J Clin Nutr 76: 1016-1022 (2002).
10. Salil G, Nevin KG Rajamohan T, Arginine rich coconut kernel protein modulates diabetes in alloxan treated rats. Chem-Biol Interact 189: 107-111 (2011).
11. Salil G Rajamohan T, Hypolipidemic and antiperoxidative effect of coconut protein in hypercholesterolemic rats. Ind J Exp Biol. 10: 1028-1034 (2001).
12. Laemmli UK, Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685 (1970).
13. Bradstreet RB, The Kjeldahl Method for Organic Nitrogen. Academic Press, New York, pp. 39-88 (1965).
14. Ishida Y, Fujita T Asai K, New detection and separation method for amino acids by high-performance liquid chromatography. J Chromatogr 204: 143-148 (1981).
15. Prince PS, Kamalakkannan N Menon VP, Antidiabetic and antihyperlipidaemic effect of alcoholic Syzigium cumini seeds in alloxan induced diabetic albino rats. J Ethnopharmacol 91: 209-213 (2004).
16. Lott JA Turner K, Evaluation of Trinder's glucose oxidase method for measuring glucose in serum and urine. Clin Chem 21: 1754-1760 (1975).
17. Carroll NV, Longley RW Roe JH, The determination of glycogen in liver and muscle by use of anthrone reagent. J Biol Chem 220: 583-593 (1956).
18. Loeb WF Stuhlman RA, A colorimetric method for the determination of serum arginase activity. Clin Chem 15: 162-169 (1969).
19. Bredt DS Snyder SH, Isolation of nitric oxide synthase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 87: 682-685 (1990).
20. Jung HC, Mun KH, Park TC, Lee YC, Park JM, Huh K, et al, Role of nitric oxide in penile erection. Yonsei Med J 38: 261-269 (1997).
21. McCord JM Fridovich J, Superoxide dismutase, an enzyme function for erythrocuprein (hemocuprein). J Biol Chem 244: 6049-6055 (1969).
22. Aebi H, Catalase in vitro. Methods Enzymol 105: 121-125 (1984).
23. Mendez JD De Haro-Hernandez R, L-Arginine and polyamine administration protect beta-cells against alloxan diabetogenic effect in Sprague-Dawley rats. Biomed Pharmacother 59: 283-289 (2005).
24. El-Missiry MA, Othman AI Amer MA, L-Arginine ameliorates oxidative stress in alloxan-induced experimental diabetes mellitus. J Appl Toxicol 24: 93-97 (2004).
25. West MB, Ramana KV, Kaiserova K, Srivastava SK Bhatnagar A, L-Arginine prevents metabolic effects of high glucose in diabetic mice. FEBS Lett. 23: 2609-2614 (2008).
26. Kochar NI Umathe SN, Beneficial effects of L-arginine against diabetes-induced oxidative stress in gastrointestinal tissues in rats. Pharmacol Rep 61: 665-672 (2009).
27. Vasilijevic A, Buzadzic B, Korac A, Petrovic V, Jankovic A Korac B, Beneficial effects of L-arginine-nitric oxide producing pathway in rats treated with alloxan. J Physiol 584: 921-933 (2007).
28. Wu G Morris SM, Arginine metabolism: nitric oxide and beyond. Biochem J 336: 1-17 (1998).
29. Reyes AA, Karl IE Klahr S, Role of arginine in health and in renal disease. Am J Physiol 267: F331-F346 (1994).
30. Visek WJ, Arginine needs, physiological state and usual diets: a reevaluation. J Nutr 116: 36-46 (1986).
31. Tenenbaum A Fisman EZ Motro M, L-Arginine: rediscovery in progress. Cardiology 90: 153-159 (1998).
32. Pieper GM Dondlinger LA, Plasma and vascular tissue arginine are decreased in diabetes: acute arginine supplementation restores endothelium-dependent relaxation by augmenting cGMP production. J Pharm Exp Ther 283: 684-691 (1997).
33. Mulloy AL, Kari FW Visek WJ, Dietary arginine, insulin secretion, glucose tolerance and liver lipids during repletion of protein-depleted rats. Hormone Met Res 14: 471-475 (1982).
34. Barbul A, Rettura G Levenson SM Seifter E, Wound healing and thymotropic effects of arginine: a pituitary mechanism of action. Am J Clin Nutr 37: 786-794 (1983).
35. Egan JM, Henderson TE Bernier M, Arginine enhances glycogen synthesis in response to insulin in 3T3 L1 adipocytes. Am J Physiol 269: E61-E66 (1995).
36. Giugliano D, Marfella R Verrazzo G, Acampora R, Coppola L, Cozzolino D, et al, The vascular effects of L-arginine in humans: the role of endogenous insulin. J Clin Invest 99: 433-438 (1997).
37. Thomas T Thomas TJ, Polyamines in cell growth and cell death: molecular mechanisms and therapeutic applications. Cell Mol Life Sci 58: 244-258 (2001).
38. Igarashi K Kashiwagi K, Polyamines: mysterious modulators of cellular functions. Biochem Biophys Res Commun 271: 559-564 (2000).
39. Morgan DM, Polyamines: an overview. Mol Biotechnol 11: 229-250 (1999).
40. Wallace HM, Polyamines: specific metabolic regulators or multifunctional polycations? Biochem Soc Trans 26: 569-571 (1998).
41. Baynes JW, Role of oxidative stress in the development of complication in diabetes. Diabetes 40: 405-412 (1991).
42. Santini SA, Marra G, Giardina B, Cotroneo P, Mordente A, Martorana GE, et al, Defective plasma antioxidant defenses and enhanced susceptibility to lipid peroxidation in uncomplicated IDDM. Diabetes 46: 1853-1858 (1997).